Number of Securities in Issue
At 28 February 2017, the Company's issued share capital consisted of 83,227,887 ordinary shares with a nominal value of 1 pence each ("Ordinary Shares"), each share having equal voting rights. There are 4,306 treasury shares in issue.
Directors & Major Shareholders
28 February 2017 - ordinary shares of 1p each
- Kestrel Investment Partners 19,544,848 (23.48%)
- Herald Investment Mgmt Ltd 7,728,026 (9.29%)
- Hargreave Hale 8,326,877 (10%)
- R M Brady 6,825,395 (8.20%)
- Coltrane asset Mgt 8,645,000 (10.39%)
- Warrington Investments Limited 5,514,003 (6.63%)
- Living Bridge 3,958,601 (4.76%)
- Octopus Investments 2,506,000 (3.01%)
- Alto Invest 1,118,374 (1.34%)
- Cazenove Capital Mgt 2,168,820 (2.61%)
- Hargreaves Lansdown Asset Mgt 1,264,815 (1.52%)
- NVM Private Equity 1,557,195 (1.87%)
- Paul Fullagar 1,453,390 (1.75%)
- Killik Asset Mgt 1,711,302 (2.06%)
- Barclays Wealth 1,580,625 (1.90%)
% of shares not held in public hands (including substantial shareholders > 10%) as at 28 February 2017 is 44%
Last Updated: 24 March 2017
The Directors intend, in so far as practiable, given the Company's size and the constitution of the Board, to comply with the provision of the Principles of Good Governance and Code of Best Practice (the "UK Corporate Governance Code") applicable to companies thatare listed on the Official List of the UKLA.
Brady plc is subject to the UK City Code on Takeovers and Mergers.
The Board is responsible for the overall management of the Group, its strategy and long-term objectives. It provides leadership to the Group, having regard to the interests of shareholders. The Board takes its corporate governance responsibilities seriously and the following statements set out the principles and methods to which it adheres.
The Chairman, in conjunction with the Chief Executive and the Company Secretary, plans the agenda for each Board meeting. That agenda is issued with supporting papers in advance of the Board meeting. These supporting papers provide the Board with appropriate information it needs to enable the Board as a whole to discharge its duties. The Board meets formally at least ten times per year to discuss strategy, direction and financial performance. The non-executive directors are invited to attend all meetings.
The Board of Brady plc comprises the Chairman, the Chief Executive, the Chief Financial Officer and four non-executive directors. As can be seen from the individual biographies, the directors have a range of experience and provide a balance of skills, experience and knowledge to the Board. The non-executive directors are deemed as independent, other than Robert Brady due to the size of his shareholding. All directors are subject to election by the shareholders at the first Annual General Meeting following their appointment, and to re-election thereafter at intervals of no more than four years.
The Board has adopted a schedule of matters specifically reserved for its approval or review, including strategic operating plans, annual operating budgets, major capital expenditure and financial commitment, including acquisitions and financial performance. The Board receive monthly management reports, which are distributed electronically and presented by the Chief Financial Officer to the whole Board for review and comment.
All directors have access to the advice and services of the Company Secretary and the directors are able to seek independent professional advice if necessary at the Company’s expense.
Click here for Matters reserved for the Board
Details of Other Exchanges or Trading Platforms
The company is not listed on any other exchanges or trading platforms
Details of Any Restrictions on the Transfer of Securities
There are no restrictions on the transfer of securities.
Country of Incorporation
Brady plc, a public limited company, is the Group’s ultimate parent company. It is registered in England and Wales. The group’s main countries of operation are the UK, Switzerland and Norway.
Cenkos Securities plc
6.7.8 Tokenhouse Yard
Barclays Bank plc
Grant Thornton UK LLP
101 Cambridge Science Park